Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017)

Eledon Pharmaceuticals' (ELDN) quarterly Amortizatization of Intangibles came in at -$1000.0 in Q1 2017, up 97.3% YoY from -$506.85 in Q1 2016, and up 83.33% on a QoQ basis from -$6000.0 in Q4 2016.

Analysis

Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends

Eledon Pharmaceuticals (ELDN) has 3 years of Amortizatization of Intangibles data on file, last reported at -$1000.0 in Q1 2017.

  • Quarterly Amortizatization of Intangibles rose 97.3% year-over-year to -$1000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$79000.0 (changed N/A YoY) and the FY2016 annual result came in at -$115000.0, down 59.72% from the prior year.
  • Amortizatization of Intangibles rose to -$1000.0 in Q1 2017, from -$6000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$1000.0 in Q1 2017 to a low of -$39000.0 in Q2 2016.
  • A 3-year average of -$26714.3 and a median of -$33000.0 in 2015 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2016 — Amortizatization of Intangibles changed 0.0% — and 2017, when it soared 97.3%.
  • Tracing ELDN's Amortizatization of Intangibles over 3 years: stood at -$38000.0 in 2015, then soared by 84.21% to -$6000.0 in 2016, then surged by 83.33% to -$1000.0 in 2017.
  • The last three Amortizatization of Intangibles figures came in at -$1000.0 (Q1 2017), -$6000.0 (Q4 2016), and -$33000.0 (Q3 2016), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -1,000.00
Dec 31, 2016 -6,000.00
Sep 30, 2016 -33,000.00
Jun 30, 2016 -39,000.00
Mar 31, 2016 -37,000.00
Dec 31, 2015 -38,000.00
Sep 30, 2015 -33,000.00